Erlotinib Active Not Recruiting Phase 1 Trials for Stage IV Pancreatic Cancer AJCC v6 and v7 / Pancreatic Adenocarcinoma Metastatic / Stage IV Pancreatic Cancer / Stage III Pancreatic Cancer AJCC v6 and v7 / Stage III Pancreatic Cancer / Recurrent Pancreatic Carcinoma Treatment

Active Not RecruitingTreatment1 IdentifierTitleDrugs
NCT01660971Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery